NORGINE LIMITED
Company Information
- Company Number
- 00215668
- Registered Address
- New Rd Tiryberth, Hengoed, Mid-Glam, S Wales, CF82 8SJ
- Status
- Active
- Employee Count
- 695
- Turnover
- £121,437,000
- EBITDA
- £10,203,000
Additional Details
- Website
- https://norgine.co.uk/
- Company Type
- Private limited Company
- Incorporated On
- 14 August 1926
- Nature of Business
- 21100 - Manufacture of basic pharmaceutical products
- Industries
- Coming Soon
- Region
- Wales
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2024 - 30 Jun 2024 | 29 Jul 2024 | 37 | 45% | 47% | 8% | 28% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 36 | 54% | 39% | 7% | 39% |
| 01 Jan 2023 - 30 Jun 2023 | 28 Jul 2023 | 32 | 57% | 40% | 3% | 23% |
| 01 Jan 2022 - 30 Jun 2022 | 20 Jul 2022 | 33 | 57% | 40% | 3% | 8% |
| 01 Jan 2021 - 30 Jun 2021 | 13 Jul 2021 | 33 | 53% | 44% | 3% | 7% |
| 01 Jan 2019 - 30 Jun 2019 | 15 Jul 2019 | 35 | 40% | 54% | 6% | 16% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 34 | 41% | 55% | 4% | 15% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms are agreed with suppliers when they are set up on our systems before the first contract is entered into. A number of historic suppliers remain on their original terms and shorter terms are offered to consultants and sole traders, but the most commonly used payment terms for new suppliers are 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
To ensure prompt processing and payment, suppliers must quote a valid Purchase Order number on all invoices and email directly to APinvoices@norgine.com. Any queries should be directed to APhelpdesk@norgine.com.
Maximum contractual payment period agreed
60
Dispute Resolution Process
We have good relationships with our suppliers and rarely have disputes relating to payments. Any queries or disputes are raised with the accounts payable team at APHelpdesk@norgine.com who then forward the query or dispute to the designated Global Purchasing contact or other relationship contact within the business, to ensure that any dispute is resolved satisfactorily for both parties.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
NORGINE LIMITED is a leading global pharmaceutical company that specializes in developing, manufacturing, and marketing innovative treatments for various gastrointestinal and liver diseases. The company was founded in 1927 and is headquartered in Dublin, Ireland.
Sustainability is a key focus for Norgine, and the company has set ambitious targets to reduce their environmental impact. They are committed to reducing their carbon footprint and have implemented various initiatives to achieve this, such as using renewable energy sources and implementing sustainable packaging practices.
Norgine offers a range of products and services that aim to improve the lives of patients suffering from gastrointestinal and liver diseases. Their portfolio includes prescription medicines, over-the-counter products, and medical devices. Some of their well-known products include MOVICOL, a laxative for the treatment of constipation, and PLENVU, a bowel cleansing agent for colonoscopies.
The company is led by a team of experienced and dedicated individuals, including CEO Peter Stein, who has over 25 years of experience in the pharmaceutical industry. Norgine also has a strong team of scientists and researchers who are committed to developing innovative treatments to improve patient outcomes.
For more information about Norgine and their products, you can visit their website at www.norgine.com. Their registered office address is Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS, United Kingdom.
